Literature DB >> 1643648

Re: W. R. Greco et al., Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res., 50: 5318-5327, 1990.

M C Berenbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1643648

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  Effects of the novel DNA dependent protein kinase inhibitor, IC486241, on the DNA damage response to doxorubicin and cisplatin in breast cancer cells.

Authors:  David Davidson; Jeremy Grenier; Veronica Martinez-Marignac; Lilian Amrein; May Shawi; Marc Tokars; Raquel Aloyz; Lawrence Panasci
Journal:  Invest New Drugs       Date:  2011-05-13       Impact factor: 3.850

2.  The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.

Authors:  David Davidson; Yunzhe Wang; Raquel Aloyz; Lawrence Panasci
Journal:  Invest New Drugs       Date:  2012-10-09       Impact factor: 3.850

3.  Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells.

Authors:  David Davidson; Yannick Coulombe; Veronica L Martinez-Marignac; Lilian Amrein; Jeremy Grenier; Keira Hodkinson; Jean-Yves Masson; Raquel Aloyz; Lawrence Panasci
Journal:  Invest New Drugs       Date:  2011-01-11       Impact factor: 3.850

4.  Modeling of tumor growth and anticancer effects of combination therapy.

Authors:  Gilbert Koch; Antje Walz; Gezim Lahu; Johannes Schropp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-04-22       Impact factor: 2.745

5.  Analyses of the combination of 6-MP and dasatinib in cell culture.

Authors:  Gurmeet Kaur; Holger Behrsing; Ralph E Parchment; Myrtle Davis Millin; Beverly A Teicher
Journal:  Int J Oncol       Date:  2013-05-02       Impact factor: 5.650

6.  Anti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine Agent.

Authors:  Ana L M Batista de Carvalho; Paula S C Medeiros; Francisco M Costa; Vanessa P Ribeiro; Joana B Sousa; Carmen Diniz; Maria P M Marques
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

7.  G-quadruplex DNA as a molecular target for induced synthetic lethality in cancer cells.

Authors:  Keith I E McLuckie; Marco Di Antonio; Heather Zecchini; Jian Xian; Carlos Caldas; Ben-Fillippo Krippendorff; David Tannahill; Christopher Lowe; Shankar Balasubramanian
Journal:  J Am Chem Soc       Date:  2013-06-25       Impact factor: 15.419

8.  Adaptive metabolic rewiring to chronic SFK inhibition.

Authors:  Edgar Pinedo-Carpio; David Davidson; Veronica L Martinez Marignac; Justin Panasci; Raquel Aloyz
Journal:  Oncotarget       Date:  2016-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.